Autism spectrum disorder in a child with megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP)

Lily Je St John1, Naveen Rao2

  • 1School of Medical Sciences, University of Manchester, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, UK lilystjohn98@gmail.com.

BMJ Case Reports
|December 31, 2021
PubMed

Insights

Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP), a PIK3CA-related disorder, can be associated with autism spectrum disorder (ASD). This report details the first known case of ASD in a child with MCAP.

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) is a rare genetic disorder.
  • It is caused by somatic mosaic mutations in the PIK3CA gene.
  • MCAP typically presents with megalencephaly, capillary malformations, and polydactyly.

Observation:

  • A 7-year-old boy with diagnosed MCAP presented with characteristic features including macrocephaly and polydactyly.
  • He developed additional clinical features over time, consistent with MCAP.
  • The patient was diagnosed with autism spectrum disorder (ASD) and demand avoidance, with further assessment for attention deficit hyperactivity disorder.

Findings:

  • This case represents the first documented instance of autism spectrum disorder (ASD) in an individual with Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP).
  • The PIK3CA gene mutation underlies MCAP and may influence neurodevelopmental outcomes.

Implications:

  • This finding expands the known clinical spectrum of MCAP.
  • Further research is needed to understand the link between PIK3CA mutations and neurodevelopmental disorders like ASD.
  • Early recognition of potential neurodevelopmental comorbidities in MCAP is crucial for timely intervention.

Related Concept Videos